Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 15848.9 | nM | 9917283 |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 1000 | nM | 21314138 | |
NPT586 | Organism | Giardia | Giardia | Potency | 460 | nM | 9822558 | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 28183.8 | nM | DrugMatrix in vitro pharmacology data | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 18526 | nM | 14738379 | |
NPT864 | Individual Protein | Lethal(3)malignant brain tumor-like protein 1 | Homo sapiens | Potency | = | 794.3 | nM | 23819871 |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 56234.1 | nM | 8254346 | |
NPT440 | Individual Protein | Quinone oxidoreductase | Mus musculus | CD | = | 4.5 | ug/ml | 23131338 |
NPT161 | Individual Protein | Rap guanine nucleotide exchange factor 4 | Homo sapiens | Potency | 56234.1 | nM | 18157122 | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 35481.3 | nM | 10.6019/CHEMBL1201861 | |
NPT2 | Others | Unspecified | Potency | 25929 | nM | 2128517 | ||
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | 21524582 | ||
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 23934.1 | nM | 20713660 | |
NPT2 | Others | Unspecified | Potency | 5011.9 | nM | 26295746 | ||
NPT2 | Others | Unspecified | Ratio | = | 1 | 18951808 | ||
NPT2 | Others | Unspecified | Potency | 16360.1 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 17782.8 | nM | 24012119 | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 39810.7 | nM | 20000781 | |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 50118.7 | nM | 10.1016/S0960-894X(00)80646-0 |
NPT2 | Others | Unspecified | Potency | = | 32642.7 | nM | PubChem BioAssay data set | |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 10000 | nM | 17190457 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 11689.1 | nM | 16252924 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 17782.8 | nM | 10869203 | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 16360.1 | nM | 12617894 | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 29092.9 | nM | 20350950 | |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 35481.3 | nM | DrugMatrix in vivo data: Hematology |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 35481.3 | nM | 10785416 | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 22387.2 | nM | 19615910 | |
NPT2 | Others | Unspecified | Potency | 1000 | nM | DrugMatrix in vitro pharmacology data | ||
NPT365 | Individual Protein | NAD(P)H dehydrogenase [quinone] 1 | Mus musculus | Ratio | = | 2.02 | 19902967 | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 79432.8 | nM | DrugMatrix in vivo data: Hematology | |
NPT2 | Others | Unspecified | Activity | = | 79 | % | 16420055 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC17848 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9848 | High Similarity | NPC161196 |
0.9774 | High Similarity | NPC157855 |
0.9773 | High Similarity | NPC46869 |
0.9635 | High Similarity | NPC59522 |
0.9632 | High Similarity | NPC52576 |
0.9565 | High Similarity | NPC179970 |
0.9562 | High Similarity | NPC62840 |
0.9562 | High Similarity | NPC217083 |
0.9562 | High Similarity | NPC293852 |
0.9562 | High Similarity | NPC299080 |
0.9562 | High Similarity | NPC59739 |
0.9562 | High Similarity | NPC78803 |
0.9562 | High Similarity | NPC214236 |
0.9559 | High Similarity | NPC472409 |
0.9559 | High Similarity | NPC150522 |
0.9545 | High Similarity | NPC101294 |
0.9545 | High Similarity | NPC473655 |
0.9489 | High Similarity | NPC103362 |
0.9485 | High Similarity | NPC11566 |
0.9481 | High Similarity | NPC259685 |
0.947 | High Similarity | NPC278556 |
0.9429 | High Similarity | NPC104406 |
0.9429 | High Similarity | NPC201731 |
0.9429 | High Similarity | NPC97716 |
0.9429 | High Similarity | NPC237635 |
0.9429 | High Similarity | NPC24673 |
0.9429 | High Similarity | NPC79469 |
0.9424 | High Similarity | NPC319752 |
0.942 | High Similarity | NPC226636 |
0.942 | High Similarity | NPC11561 |
0.9416 | High Similarity | NPC241100 |
0.9416 | High Similarity | NPC159275 |
0.9407 | High Similarity | NPC254741 |
0.9398 | High Similarity | NPC229646 |
0.9362 | High Similarity | NPC6511 |
0.9362 | High Similarity | NPC244407 |
0.9362 | High Similarity | NPC321623 |
0.9362 | High Similarity | NPC161191 |
0.9362 | High Similarity | NPC189087 |
0.9362 | High Similarity | NPC266572 |
0.9357 | High Similarity | NPC88964 |
0.9357 | High Similarity | NPC470647 |
0.9357 | High Similarity | NPC312973 |
0.9357 | High Similarity | NPC246948 |
0.9357 | High Similarity | NPC142405 |
0.9357 | High Similarity | NPC474161 |
0.9357 | High Similarity | NPC54577 |
0.9357 | High Similarity | NPC67805 |
0.9357 | High Similarity | NPC475052 |
0.9357 | High Similarity | NPC83357 |
0.9357 | High Similarity | NPC301276 |
0.9357 | High Similarity | NPC476088 |
0.9357 | High Similarity | NPC111786 |
0.9357 | High Similarity | NPC20488 |
0.9357 | High Similarity | NPC195621 |
0.9357 | High Similarity | NPC267375 |
0.9357 | High Similarity | NPC176229 |
0.9357 | High Similarity | NPC214774 |
0.9353 | High Similarity | NPC38219 |
0.9353 | High Similarity | NPC219915 |
0.9348 | High Similarity | NPC110969 |
0.9348 | High Similarity | NPC64908 |
0.9348 | High Similarity | NPC282300 |
0.9348 | High Similarity | NPC156590 |
0.9348 | High Similarity | NPC147688 |
0.9348 | High Similarity | NPC205006 |
0.9348 | High Similarity | NPC118840 |
0.9343 | High Similarity | NPC78913 |
0.9343 | High Similarity | NPC217186 |
0.9343 | High Similarity | NPC96565 |
0.9343 | High Similarity | NPC301217 |
0.9343 | High Similarity | NPC220062 |
0.9343 | High Similarity | NPC216978 |
0.9343 | High Similarity | NPC303633 |
0.9343 | High Similarity | NPC53181 |
0.9343 | High Similarity | NPC18260 |
0.9343 | High Similarity | NPC55018 |
0.9333 | High Similarity | NPC99854 |
0.9328 | High Similarity | NPC292998 |
0.9323 | High Similarity | NPC284424 |
0.9296 | High Similarity | NPC5173 |
0.9291 | High Similarity | NPC282335 |
0.9291 | High Similarity | NPC296998 |
0.9291 | High Similarity | NPC166757 |
0.9291 | High Similarity | NPC218300 |
0.9291 | High Similarity | NPC473077 |
0.9291 | High Similarity | NPC23728 |
0.9291 | High Similarity | NPC283234 |
0.9291 | High Similarity | NPC110303 |
0.9291 | High Similarity | NPC14001 |
0.9286 | High Similarity | NPC311741 |
0.9286 | High Similarity | NPC234629 |
0.9281 | High Similarity | NPC147145 |
0.9275 | High Similarity | NPC475680 |
0.9275 | High Similarity | NPC172986 |
0.9275 | High Similarity | NPC270883 |
0.9275 | High Similarity | NPC235239 |
0.9275 | High Similarity | NPC261227 |
0.9275 | High Similarity | NPC305355 |
0.927 | High Similarity | NPC201395 |
0.9265 | High Similarity | NPC72452 |
0.9265 | High Similarity | NPC61546 |
0.9259 | High Similarity | NPC125269 |
0.9231 | High Similarity | NPC188403 |
0.9231 | High Similarity | NPC189270 |
0.9231 | High Similarity | NPC5840 |
0.9225 | High Similarity | NPC160821 |
0.9225 | High Similarity | NPC296869 |
0.9225 | High Similarity | NPC132592 |
0.922 | High Similarity | NPC220418 |
0.922 | High Similarity | NPC57470 |
0.922 | High Similarity | NPC124729 |
0.9214 | High Similarity | NPC316816 |
0.9214 | High Similarity | NPC106985 |
0.9214 | High Similarity | NPC478086 |
0.9214 | High Similarity | NPC17262 |
0.9214 | High Similarity | NPC166138 |
0.9214 | High Similarity | NPC18585 |
0.9214 | High Similarity | NPC214166 |
0.9209 | High Similarity | NPC22467 |
0.9209 | High Similarity | NPC14871 |
0.9203 | High Similarity | NPC473209 |
0.9203 | High Similarity | NPC23257 |
0.9197 | High Similarity | NPC38153 |
0.9197 | High Similarity | NPC253616 |
0.9185 | High Similarity | NPC223354 |
0.9167 | High Similarity | NPC473907 |
0.9161 | High Similarity | NPC164299 |
0.9155 | High Similarity | NPC297886 |
0.9155 | High Similarity | NPC180477 |
0.9155 | High Similarity | NPC249942 |
0.9149 | High Similarity | NPC257236 |
0.9149 | High Similarity | NPC278175 |
0.9149 | High Similarity | NPC209040 |
0.9149 | High Similarity | NPC273538 |
0.9149 | High Similarity | NPC131568 |
0.9149 | High Similarity | NPC469953 |
0.9149 | High Similarity | NPC216538 |
0.9149 | High Similarity | NPC131579 |
0.9143 | High Similarity | NPC220998 |
0.9143 | High Similarity | NPC328164 |
0.9143 | High Similarity | NPC10937 |
0.9143 | High Similarity | NPC228504 |
0.9143 | High Similarity | NPC32739 |
0.9143 | High Similarity | NPC265040 |
0.9143 | High Similarity | NPC324436 |
0.9143 | High Similarity | NPC223500 |
0.9143 | High Similarity | NPC76372 |
0.9143 | High Similarity | NPC64915 |
0.9143 | High Similarity | NPC66515 |
0.9143 | High Similarity | NPC182852 |
0.9143 | High Similarity | NPC161506 |
0.9143 | High Similarity | NPC324134 |
0.9143 | High Similarity | NPC107572 |
0.9143 | High Similarity | NPC37496 |
0.9143 | High Similarity | NPC78 |
0.9143 | High Similarity | NPC166934 |
0.9143 | High Similarity | NPC306829 |
0.9143 | High Similarity | NPC76338 |
0.9143 | High Similarity | NPC177354 |
0.9143 | High Similarity | NPC40833 |
0.9143 | High Similarity | NPC148757 |
0.9143 | High Similarity | NPC125855 |
0.9143 | High Similarity | NPC166482 |
0.9143 | High Similarity | NPC167624 |
0.9143 | High Similarity | NPC194432 |
0.9143 | High Similarity | NPC144499 |
0.9143 | High Similarity | NPC296917 |
0.9143 | High Similarity | NPC200694 |
0.9143 | High Similarity | NPC1089 |
0.9143 | High Similarity | NPC227579 |
0.9137 | High Similarity | NPC471587 |
0.9137 | High Similarity | NPC69769 |
0.9137 | High Similarity | NPC171094 |
0.913 | High Similarity | NPC470669 |
0.913 | High Similarity | NPC254168 |
0.913 | High Similarity | NPC131130 |
0.913 | High Similarity | NPC248995 |
0.913 | High Similarity | NPC272844 |
0.913 | High Similarity | NPC276905 |
0.913 | High Similarity | NPC470668 |
0.9124 | High Similarity | NPC174999 |
0.9124 | High Similarity | NPC127447 |
0.9124 | High Similarity | NPC473887 |
0.9124 | High Similarity | NPC194281 |
0.9124 | High Similarity | NPC234133 |
0.9124 | High Similarity | NPC231772 |
0.9124 | High Similarity | NPC29353 |
0.9124 | High Similarity | NPC47815 |
0.9124 | High Similarity | NPC13408 |
0.9124 | High Similarity | NPC124784 |
0.9124 | High Similarity | NPC268081 |
0.9111 | High Similarity | NPC182428 |
0.9098 | High Similarity | NPC473894 |
0.9098 | High Similarity | NPC211120 |
0.9097 | High Similarity | NPC471984 |
0.9097 | High Similarity | NPC472633 |
0.9097 | High Similarity | NPC29777 |
0.9097 | High Similarity | NPC471115 |
0.9091 | High Similarity | NPC41721 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC17848 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9265 | High Similarity | NPD2796 | Approved |
0.9149 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.9149 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8786 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.8786 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.8776 | High Similarity | NPD7411 | Suspended |
0.8723 | High Similarity | NPD1549 | Phase 2 |
0.8643 | High Similarity | NPD1510 | Phase 2 |
0.8623 | High Similarity | NPD1240 | Approved |
0.86 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8591 | High Similarity | NPD6801 | Discontinued |
0.8581 | High Similarity | NPD4380 | Phase 2 |
0.8552 | High Similarity | NPD6799 | Approved |
0.8533 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8533 | High Similarity | NPD7819 | Suspended |
0.8533 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8531 | High Similarity | NPD1243 | Approved |
0.8511 | High Similarity | NPD3748 | Approved |
0.85 | High Similarity | NPD1607 | Approved |
0.8378 | Intermediate Similarity | NPD920 | Approved |
0.8377 | Intermediate Similarity | NPD5494 | Approved |
0.8366 | Intermediate Similarity | NPD7075 | Discontinued |
0.8356 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD6599 | Discontinued |
0.8299 | Intermediate Similarity | NPD1511 | Approved |
0.8289 | Intermediate Similarity | NPD2801 | Approved |
0.8276 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8255 | Intermediate Similarity | NPD5403 | Approved |
0.8247 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8243 | Intermediate Similarity | NPD5401 | Approved |
0.8243 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.8235 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8224 | Intermediate Similarity | NPD1934 | Approved |
0.8219 | Intermediate Similarity | NPD3750 | Approved |
0.8214 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8188 | Intermediate Similarity | NPD1512 | Approved |
0.8182 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8165 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8125 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8089 | Intermediate Similarity | NPD6959 | Discontinued |
0.8088 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.8071 | Intermediate Similarity | NPD6832 | Phase 2 |
0.8027 | Intermediate Similarity | NPD2800 | Approved |
0.8013 | Intermediate Similarity | NPD3749 | Approved |
0.8 | Intermediate Similarity | NPD2799 | Discontinued |
0.7986 | Intermediate Similarity | NPD6651 | Approved |
0.7962 | Intermediate Similarity | NPD919 | Approved |
0.7959 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7958 | Intermediate Similarity | NPD2313 | Discontinued |
0.7949 | Intermediate Similarity | NPD3882 | Suspended |
0.7937 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7937 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7937 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7905 | Intermediate Similarity | NPD2654 | Approved |
0.7885 | Intermediate Similarity | NPD5402 | Approved |
0.7862 | Intermediate Similarity | NPD1247 | Approved |
0.7857 | Intermediate Similarity | NPD3267 | Approved |
0.7857 | Intermediate Similarity | NPD3266 | Approved |
0.7823 | Intermediate Similarity | NPD2935 | Discontinued |
0.7823 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7818 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7801 | Intermediate Similarity | NPD2798 | Approved |
0.7793 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7793 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7791 | Intermediate Similarity | NPD7054 | Approved |
0.777 | Intermediate Similarity | NPD3972 | Approved |
0.7764 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7755 | Intermediate Similarity | NPD7033 | Discontinued |
0.7744 | Intermediate Similarity | NPD7472 | Approved |
0.7744 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7742 | Intermediate Similarity | NPD6585 | Discontinued |
0.773 | Intermediate Similarity | NPD3818 | Discontinued |
0.7724 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7708 | Intermediate Similarity | NPD3268 | Approved |
0.7708 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7708 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7702 | Intermediate Similarity | NPD6232 | Discontinued |
0.7697 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7697 | Intermediate Similarity | NPD5953 | Discontinued |
0.7692 | Intermediate Similarity | NPD5890 | Approved |
0.7692 | Intermediate Similarity | NPD5889 | Approved |
0.7683 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7671 | Intermediate Similarity | NPD1933 | Approved |
0.7669 | Intermediate Similarity | NPD7473 | Discontinued |
0.7662 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.766 | Intermediate Similarity | NPD3225 | Approved |
0.7651 | Intermediate Similarity | NPD2344 | Approved |
0.7651 | Intermediate Similarity | NPD7251 | Discontinued |
0.7647 | Intermediate Similarity | NPD2534 | Approved |
0.7647 | Intermediate Similarity | NPD2533 | Approved |
0.7647 | Intermediate Similarity | NPD2532 | Approved |
0.7616 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.761 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7607 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD1203 | Approved |
0.7606 | Intermediate Similarity | NPD2797 | Approved |
0.7605 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7584 | Intermediate Similarity | NPD6100 | Approved |
0.7584 | Intermediate Similarity | NPD6099 | Approved |
0.7576 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7569 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7564 | Intermediate Similarity | NPD3226 | Approved |
0.7556 | Intermediate Similarity | NPD1241 | Discontinued |
0.7551 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7545 | Intermediate Similarity | NPD6559 | Discontinued |
0.7536 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7533 | Intermediate Similarity | NPD2346 | Discontinued |
0.7518 | Intermediate Similarity | NPD9717 | Approved |
0.7517 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD4308 | Phase 3 |
0.75 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7471 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7471 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7468 | Intermediate Similarity | NPD7390 | Discontinued |
0.7451 | Intermediate Similarity | NPD2309 | Approved |
0.7447 | Intermediate Similarity | NPD422 | Phase 1 |
0.7438 | Intermediate Similarity | NPD4288 | Approved |
0.7431 | Intermediate Similarity | NPD1019 | Discontinued |
0.7429 | Intermediate Similarity | NPD17 | Approved |
0.7417 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7394 | Intermediate Similarity | NPD2403 | Approved |
0.7386 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD943 | Approved |
0.7358 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7338 | Intermediate Similarity | NPD3295 | Clinical (unspecified phase) |
0.7338 | Intermediate Similarity | NPD3887 | Approved |
0.733 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.733 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7329 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7324 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7305 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7303 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7303 | Intermediate Similarity | NPD2353 | Approved |
0.7292 | Intermediate Similarity | NPD1876 | Approved |
0.7279 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7273 | Intermediate Similarity | NPD1608 | Approved |
0.7248 | Intermediate Similarity | NPD3140 | Approved |
0.7248 | Intermediate Similarity | NPD3142 | Approved |
0.7234 | Intermediate Similarity | NPD1651 | Approved |
0.7233 | Intermediate Similarity | NPD7458 | Discontinued |
0.723 | Intermediate Similarity | NPD6798 | Discontinued |
0.7226 | Intermediate Similarity | NPD5535 | Approved |
0.7219 | Intermediate Similarity | NPD1729 | Discontinued |
0.7205 | Intermediate Similarity | NPD6280 | Approved |
0.7205 | Intermediate Similarity | NPD6279 | Approved |
0.7197 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7176 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7169 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7161 | Intermediate Similarity | NPD7003 | Approved |
0.716 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7152 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7135 | Intermediate Similarity | NPD6104 | Discontinued |
0.7125 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.712 | Intermediate Similarity | NPD7584 | Approved |
0.7115 | Intermediate Similarity | NPD2354 | Approved |
0.7099 | Intermediate Similarity | NPD6844 | Discontinued |
0.7089 | Intermediate Similarity | NPD4661 | Approved |
0.7089 | Intermediate Similarity | NPD4662 | Approved |
0.7078 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7066 | Intermediate Similarity | NPD3787 | Discontinued |
0.7066 | Intermediate Similarity | NPD5710 | Approved |
0.7066 | Intermediate Similarity | NPD5711 | Approved |
0.7066 | Intermediate Similarity | NPD6808 | Phase 2 |
0.7062 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD4287 | Approved |
0.7042 | Intermediate Similarity | NPD9545 | Approved |
0.7032 | Intermediate Similarity | NPD2424 | Discontinued |
0.7025 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7021 | Intermediate Similarity | NPD9493 | Approved |
0.7019 | Intermediate Similarity | NPD8158 | Clinical (unspecified phase) |
0.7013 | Intermediate Similarity | NPD5405 | Approved |
0.7013 | Intermediate Similarity | NPD5406 | Approved |
0.7013 | Intermediate Similarity | NPD5404 | Approved |
0.7013 | Intermediate Similarity | NPD4477 | Approved |
0.7013 | Intermediate Similarity | NPD5408 | Approved |
0.7013 | Intermediate Similarity | NPD4476 | Approved |
0.7006 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7 | Intermediate Similarity | NPD3751 | Discontinued |
0.7 | Intermediate Similarity | NPD411 | Approved |
0.7 | Intermediate Similarity | NPD5940 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD3764 | Approved |
0.6994 | Remote Similarity | NPD7577 | Discontinued |
0.6987 | Remote Similarity | NPD1652 | Phase 2 |
0.6986 | Remote Similarity | NPD4749 | Approved |
0.698 | Remote Similarity | NPD1529 | Clinical (unspecified phase) |
0.6978 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD447 | Suspended |
0.6974 | Remote Similarity | NPD6355 | Discontinued |
0.697 | Remote Similarity | NPD5019 | Clinical (unspecified phase) |
0.6966 | Remote Similarity | NPD1281 | Approved |
0.6966 | Remote Similarity | NPD1201 | Approved |
0.6954 | Remote Similarity | NPD6233 | Phase 2 |
0.6951 | Remote Similarity | NPD8455 | Phase 2 |
0.6943 | Remote Similarity | NPD7466 | Approved |
0.6937 | Remote Similarity | NPD6273 | Approved |
0.6928 | Remote Similarity | NPD6971 | Discontinued |
0.6923 | Remote Similarity | NPD1894 | Discontinued |
0.6923 | Remote Similarity | NPD5242 | Approved |
PubChem CID   | 10958572 |
ChEMBL   | CHEMBL454843 |
ZINC   |
Molecular Weight:   | 334.12 |
ALogP:   | 0.3524 |
MLogP:   | 3.33 |
XLogP:   | 5.082 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 44.76 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 4 |
# Heavy Atoms:   | 25 |